Dr Chris Peters

Chris Peters is an Imperial College academic surgeon with a specialist interest in transitioning new technologies to the patient. Chris went to medical school in Leeds and after completing basic surgical training moved to Cambridge to carry out a PhD with Professor Rebecca Fitzgerald. He also jointly set up the OCCAMS collaboration which ran the International Cancer Genome Consortium's Whole Genome sequencing project in oesophageal adenocarcinoma. OCCAMS has now recruited in excess of 4000 patients and resulted in over 35 publications including in Nature, Nature Genetics, and Nature Communications. 

As the Biomarker lead for the NIHR HealthTech Research Centre’s In-vitro Diagnostics Group he has a research programme to understand which biomarkers are likely to achieve clinical adoption. This led to the creation of the Biomarker Toolkit, which assesses the quality of a biomarker and guides its future development. 

Chris is also the gastric cancer lead for the NIHR funded trial of PIPAC in cancers of the Colon, Ovary and Stomach (PICCOS) and also  the co founder of the UK and Ireland Oesophagogastric Cancer Group.